Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.
Many companies overlook the potential of new applications for products they have sold for years.
Erwin Danneels and Federico Frattini
When it comes to patent policies, the U.S. system is not broken — so lawmakers shouldn’t fix it.
David J. Kappos
Companies often struggle to establish and run university partnerships effectively.
Lars Frølund, Fiona Murray, and Max Riedel
Open-innovation platforms, used thoughtfully, can expand a company’s access to analytics talent.
Joseph Byrum and Alpheus Bingham
High-impact innovations have built-in uncertainty — but careful strategizing can reduce the risk.
Joseph V. Sinfield and Freddy Solis
Project-centered governance may be an efficient way to organize innovation in fields such as biotech.